Procter & Gamble Seen With Path to Growth Trajectory in 2H -- Market Talk

Dow Jones01-23 23:49

1049 ET - Procter & Gamble could be poised to accelerate its organic sales growth after a challenging first half to its fiscal year, JPMorgan analyst Andrea Teixeira writes in a note, upgrading the stock to overweight. "At the earnings call Thursday morning, management gave much needed and hoped for reassurance that the company is on the right track to sequentially improve OSG from flat in FQ2 (1% in F1H) to about 2-3% in F2H," she writes. There are execution risks, she writes, but several factors are looking up for the back half of the fiscal year: underlying category growth improvement, the company lapping tough comps leaving the second quarter, and intervention tactics to stimulate growth that proved successful internationally. The worst seems to be behind, she writes. Procter & Gamble is up 1%.(elias.schisgall@wsj.com)

 

(END) Dow Jones Newswires

January 23, 2026 10:49 ET (15:49 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment